| Literature DB >> 24239923 |
Neil J Stone, Jennifer G Robinson, Alice H Lichtenstein, C Noel Bairey Merz, Conrad B Blum, Robert H Eckel, Anne C Goldberg, David Gordon, Daniel Levy, Donald M Lloyd-Jones, Patrick McBride, J Sanford Schwartz, Susan T Shero, Sidney C Smith, Karol Watson, Peter W F Wilson.
Abstract
Entities:
Keywords: ACC/AHA Practice Guideline; biomarkers, pharmacological; cardiovascular disease; cholesterol; diabetes mellitus; drug therapy; hydroxymethylglutaryl-CoA reductase inhibitors/statins; hypercholesterolemia; lipids; patient compliance; primary prevention; risk assessment; risk reduction behavior; secondary prevention
Mesh:
Substances:
Year: 2013 PMID: 24239923 DOI: 10.1016/j.jacc.2013.11.002
Source DB: PubMed Journal: J Am Coll Cardiol ISSN: 0735-1097 Impact factor: 24.094